Human Cell Reprogramming for Aging and Alzheimer's Disease Research (R21)

Archived

National Institutes of Health

View on Grants.gov 📝 Build a proposal template ★ Save

Description

The purpose of this FOA is to support the development of human induced pluripotent stem (iPS) cells and other reprogrammed cells for aging and Alzheimers disease modeling. The molecular and functional characterization of aged or Alzheimers disease phenotypes in specific cell types derived from human iPS and other reprogrammed cells is expected to provide proof-of-concept evidence that human reprogrammed cells can be valid cell models of aging and Alzheimers disease.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedAug 3, 2011
  • ClosesNov 2, 2011
  • Award ceiling$200,000
  • Program funding$1,200,000
  • CFDA93.866
Categories
Health

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro